Climb Bio, Inc. (CLYM)
5.67
+0.40
(+7.59%)
USD |
NASDAQ |
Feb 13, 16:00
5.68
+0.01
(+0.18%)
After-Hours: 20:00
Climb Bio Shareholders Equity (Quarterly) : 177.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Fortress Biotech, Inc. | 55.86M |
| Oramed Pharmaceuticals, Inc. | 203.28M |
| Lyell Immunopharma, Inc. | 329.12M |
| PepGen Inc. | 163.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.30M |
| Total Liabilities (Quarterly) | 5.301M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 18.38 |
| Net Debt Paydown Yield | -0.07% |